↓ Skip to main content

Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients

Overview of attention for article published in Future Science OA, February 2021

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

guideline
2 clinical guideline sources

Readers on

mendeley
10 Mendeley